Management of Angina: Coronary Artery Disease vs Aortic Regurgitation

Angina Management in Coronary Artery Disease

The European Society of Cardiology recommends beta-blockers as the cornerstone of initial therapy for chronic stable angina due to CAD, targeting a resting heart rate of 55-60 beats per minute 1, 2
Beta-blockers reduce cardiac events and mortality, particularly in patients with prior myocardial infarction and those with diabetes, with a strength of evidence level of A 3, 4
Aspirin 75-150 mg daily is mandatory for all patients with established CAD to prevent cardiovascular events, as recommended by the American College of Cardiology 3, 4, 2
High-intensity statin therapy (atorvastatin 40-80 mg daily or rosuvastatin 20-40 mg daily) is essential, targeting LDL cholesterol <70 mg/dL, as recommended by the American Heart Association 3, 4, 2
ACE inhibitors (ramipril 10 mg daily or perindopril 8 mg daily) provide vascular protection beyond blood pressure control and reduce cardiovascular death, MI, and stroke, as recommended by the European Society of Cardiology 3, 4, 2

Beta-blockers are contraindicated in aortic regurgitation because they reduce heart rate and increase diastolic filling time, which worsens regurgitant volume and left ventricular volume overload, as stated by the European Heart Journal 1
Dihydropyridine calcium channel blockers (amlodipine, nifedipine long-acting) are preferred as they reduce afterload without significantly decreasing heart rate, as recommended by the American College of Cardiology 1
ACE inhibitors or angiotensin receptor blockers reduce afterload and are beneficial for chronic aortic regurgitation management, as recommended by the American Heart Association 3, 4

Never use beta-blockers in aortic regurgitation - this is a fundamental contraindication that will worsen hemodynamics and symptoms, as warned by the European Heart Journal 1
Do not use immediate-release or short-acting dihydropyridine calcium antagonists in CAD, as they increase adverse cardiac events, as warned by the American College of Cardiology 3, 4
Diabetes mellitus is not a contraindication to beta-blocker use in CAD; diabetic patients benefit as much as or more than non-diabetic patients, as stated by the American Diabetes Association 3, 4

For CAD patients on beta-blockers, optimize the dose before adding additional antianginal agents, as recommended by the European Society of Cardiology 2
Reassess angina symptoms at each visit and adjust anti-ischemic medication as needed, as recommended by the American College of Cardiology 2
In aortic regurgitation, serial echocardiography is essential to monitor left ventricular size and function, guiding timing of surgical intervention, as recommended by the American Heart Association 2